SlideShare a Scribd company logo
1 of 1
Download to read offline
K AEMMERER GRO U P, LLC PORTFOLIO EXAMPLE
Kaemmerer Group, LLC • www.kaemmerergroup.com • info@kaemmerergroup.com • 612.293.5448 • www.linkedin.com/in/carolkaemmerer
Client:	 Medtronic, Inc.
Project:	 Monograph for healthcare payers
on electrical neurostimulation for
gastroparesis
Objective:	 This 16-page monograph sets the stage
for healthcare payers to be willing to pay
for a new therapy for a rare disease.
Description of	 This monograph explains the rare
monograph: 	 condition of gastroparesis, the various
treatment options for this condition, and
introduces a Medtronic therapy that has
a Humanitarian Device Exemption for
gastroparesis, Enterra®
Therapy. Clinical
literature is summarized and referenced.
Visual elements
Because the audience for this monograph is healthcare payers
and Medtronic’s message was to educate rather to make a sale, we
deliberately chose a simple, two-color format.
The treatment algorithm (see blue box at right) is something that
communicates efficiently to our audience of healthcare payers.
It indicates the steps that a doctor would take in the process of
diagnosing gastroparesis and in what order treatment options
would be used to address symptoms. Note that Enterra Therapy
is near the bottom of the treatment algorithm. This indicates
that it is appropriate to treat the condition with other more
conservative therapies before considering Enterra Therapy which
involves an implantable medical device.
Copy close-up
“Prokinetic drugs can be used to promote gastric emptying.
Metoclopramide (Reglan®
), which has both prokinetic and
antiemetic properties, is the only drug approved for the
treatment of diabetic gastroparesis. Metoclopramide has
central dopanergic actions that may result in such severe
central nervous system side effects that 10% of patients are
required to withdraw from medication. Controlled studies
have shown that cisapride (Propulsid®
) can improve gastric
emptying, but not other symptoms of gastroparesis.3-7
…
Prokinetic drugs are associated with side effects such as
cardiac arrhythmias, abdominal cramping, diarrhea, and
nervousness.”
[End of excerpt.]
Note the didactic, factual style of the writing, which is
appropriate to the audience for the piece and its purpose. Clinical
literature is referenced throughout the monograph.

More Related Content

Viewers also liked (15)

τα οπλα του αγωνα
τα οπλα του αγωνατα οπλα του αγωνα
τα οπλα του αγωνα
 
Design Thinking: Native Hawaiian Plants
Design Thinking: Native Hawaiian PlantsDesign Thinking: Native Hawaiian Plants
Design Thinking: Native Hawaiian Plants
 
ελληνικη επανασταση 1821
ελληνικη επανασταση 1821ελληνικη επανασταση 1821
ελληνικη επανασταση 1821
 
Oi πρωταγωνιστες του 1821
Oi πρωταγωνιστες του 1821Oi πρωταγωνιστες του 1821
Oi πρωταγωνιστες του 1821
 
4 1
4 14 1
4 1
 
Sc1362
Sc1362Sc1362
Sc1362
 
Drupal 8: Most common beginner mistakes
Drupal 8: Most common beginner mistakesDrupal 8: Most common beginner mistakes
Drupal 8: Most common beginner mistakes
 
Intro to Shared Decision Making
Intro to Shared Decision MakingIntro to Shared Decision Making
Intro to Shared Decision Making
 
Títulos de renta fija: Bonos.
Títulos de renta fija: Bonos.Títulos de renta fija: Bonos.
Títulos de renta fija: Bonos.
 
Портфоліо класного керівника
Портфоліо класного керівникаПортфоліо класного керівника
Портфоліо класного керівника
 
පරිගණක පරිණාමය Evolution of Computer sinhala
පරිගණක පරිණාමය Evolution of Computer sinhalaපරිගණක පරිණාමය Evolution of Computer sinhala
පරිගණක පරිණාමය Evolution of Computer sinhala
 
RHBC Announcements 01/01/17
RHBC Announcements 01/01/17RHBC Announcements 01/01/17
RHBC Announcements 01/01/17
 
自己結合Sqlクエリ検出ツールによるチューニングの提案
自己結合Sqlクエリ検出ツールによるチューニングの提案自己結合Sqlクエリ検出ツールによるチューニングの提案
自己結合Sqlクエリ検出ツールによるチューニングの提案
 
Ing40
Ing40Ing40
Ing40
 
TÉCNICAS DE ESTUDIO(RESUMEN)
TÉCNICAS DE ESTUDIO(RESUMEN) TÉCNICAS DE ESTUDIO(RESUMEN)
TÉCNICAS DE ESTUDIO(RESUMEN)
 

Similar to Payer information Humanitarian Use Device therapy for gastroparesis

Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4Javeriya_PPCD
 
Personalized Medicines - Enhancers of Life's Quality and Their Future
 Personalized Medicines - Enhancers of Life's Quality and Their Future  Personalized Medicines - Enhancers of Life's Quality and Their Future
Personalized Medicines - Enhancers of Life's Quality and Their Future SindhBiotech
 
Personalized Medicine - New.docx
Personalized Medicine - New.docxPersonalized Medicine - New.docx
Personalized Medicine - New.docxVenkatesh Sadhu
 
Mechanism of Action and Clinical Use of PPIs and Prokinetic Agents.docx
Mechanism of Action and Clinical Use of PPIs and Prokinetic Agents.docxMechanism of Action and Clinical Use of PPIs and Prokinetic Agents.docx
Mechanism of Action and Clinical Use of PPIs and Prokinetic Agents.docxjessiehampson
 
Poster for essay
Poster for essayPoster for essay
Poster for essaykaren frend
 
Comparitive Study of the Efficacy and Tolerance of Prokinetic Drugs - Metaclo...
Comparitive Study of the Efficacy and Tolerance of Prokinetic Drugs - Metaclo...Comparitive Study of the Efficacy and Tolerance of Prokinetic Drugs - Metaclo...
Comparitive Study of the Efficacy and Tolerance of Prokinetic Drugs - Metaclo...pharmaindexing
 
DDS personalised medicines M.Pharma 1st Sem Pharmaceutics.pptx
DDS personalised medicines M.Pharma 1st Sem Pharmaceutics.pptxDDS personalised medicines M.Pharma 1st Sem Pharmaceutics.pptx
DDS personalised medicines M.Pharma 1st Sem Pharmaceutics.pptxkushaltegginamani18
 
PANEL DISCUSSION ON ENDOMETRIOSIS IN ADOLESCENTS (2018 )
PANEL DISCUSSION ON ENDOMETRIOSIS IN ADOLESCENTS (2018 )PANEL DISCUSSION ON ENDOMETRIOSIS IN ADOLESCENTS (2018 )
PANEL DISCUSSION ON ENDOMETRIOSIS IN ADOLESCENTS (2018 )Lifecare Centre
 
A Systematic Review on the Efficacy of Iontophoresis as a Treatment for Later...
A Systematic Review on the Efficacy of Iontophoresis as a Treatment for Later...A Systematic Review on the Efficacy of Iontophoresis as a Treatment for Later...
A Systematic Review on the Efficacy of Iontophoresis as a Treatment for Later...Crimsonpublishers-Sportsmedicine
 
The Future of Pharma Industry Trends and Innovations.pptx
The Future of Pharma Industry Trends and Innovations.pptxThe Future of Pharma Industry Trends and Innovations.pptx
The Future of Pharma Industry Trends and Innovations.pptxMediwinpharma
 
OMEPRAZOLE AND CLOPIDOGREL INTERACTION: CURRENT RECOMMENDATIONS
OMEPRAZOLE AND CLOPIDOGREL INTERACTION: CURRENT RECOMMENDATIONSOMEPRAZOLE AND CLOPIDOGREL INTERACTION: CURRENT RECOMMENDATIONS
OMEPRAZOLE AND CLOPIDOGREL INTERACTION: CURRENT RECOMMENDATIONSDoc Tony Comia
 
Therapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptxTherapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptxNoumanMomin1
 
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docxherminaprocter
 
Therapeutics-1-Copy.pdf
Therapeutics-1-Copy.pdfTherapeutics-1-Copy.pdf
Therapeutics-1-Copy.pdfssuser9127b3
 
Thesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyThesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyHA VO THI
 
The-Case-for-Practice-Integration[1]
The-Case-for-Practice-Integration[1]The-Case-for-Practice-Integration[1]
The-Case-for-Practice-Integration[1]Amy Williams
 

Similar to Payer information Humanitarian Use Device therapy for gastroparesis (20)

Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
 
Personalized Medicines - Enhancers of Life's Quality and Their Future
 Personalized Medicines - Enhancers of Life's Quality and Their Future  Personalized Medicines - Enhancers of Life's Quality and Their Future
Personalized Medicines - Enhancers of Life's Quality and Their Future
 
Personalized Medicine - New.docx
Personalized Medicine - New.docxPersonalized Medicine - New.docx
Personalized Medicine - New.docx
 
Mechanism of Action and Clinical Use of PPIs and Prokinetic Agents.docx
Mechanism of Action and Clinical Use of PPIs and Prokinetic Agents.docxMechanism of Action and Clinical Use of PPIs and Prokinetic Agents.docx
Mechanism of Action and Clinical Use of PPIs and Prokinetic Agents.docx
 
Poster for essay
Poster for essayPoster for essay
Poster for essay
 
Comparitive Study of the Efficacy and Tolerance of Prokinetic Drugs - Metaclo...
Comparitive Study of the Efficacy and Tolerance of Prokinetic Drugs - Metaclo...Comparitive Study of the Efficacy and Tolerance of Prokinetic Drugs - Metaclo...
Comparitive Study of the Efficacy and Tolerance of Prokinetic Drugs - Metaclo...
 
DDS personalised medicines M.Pharma 1st Sem Pharmaceutics.pptx
DDS personalised medicines M.Pharma 1st Sem Pharmaceutics.pptxDDS personalised medicines M.Pharma 1st Sem Pharmaceutics.pptx
DDS personalised medicines M.Pharma 1st Sem Pharmaceutics.pptx
 
PANEL DISCUSSION ON ENDOMETRIOSIS IN ADOLESCENTS (2018 )
PANEL DISCUSSION ON ENDOMETRIOSIS IN ADOLESCENTS (2018 )PANEL DISCUSSION ON ENDOMETRIOSIS IN ADOLESCENTS (2018 )
PANEL DISCUSSION ON ENDOMETRIOSIS IN ADOLESCENTS (2018 )
 
A Systematic Review on the Efficacy of Iontophoresis as a Treatment for Later...
A Systematic Review on the Efficacy of Iontophoresis as a Treatment for Later...A Systematic Review on the Efficacy of Iontophoresis as a Treatment for Later...
A Systematic Review on the Efficacy of Iontophoresis as a Treatment for Later...
 
Hyperprolactinemia endocrin society
Hyperprolactinemia endocrin societyHyperprolactinemia endocrin society
Hyperprolactinemia endocrin society
 
P-DRUG.pptx
P-DRUG.pptxP-DRUG.pptx
P-DRUG.pptx
 
The Future of Pharma Industry Trends and Innovations.pptx
The Future of Pharma Industry Trends and Innovations.pptxThe Future of Pharma Industry Trends and Innovations.pptx
The Future of Pharma Industry Trends and Innovations.pptx
 
OMEPRAZOLE AND CLOPIDOGREL INTERACTION: CURRENT RECOMMENDATIONS
OMEPRAZOLE AND CLOPIDOGREL INTERACTION: CURRENT RECOMMENDATIONSOMEPRAZOLE AND CLOPIDOGREL INTERACTION: CURRENT RECOMMENDATIONS
OMEPRAZOLE AND CLOPIDOGREL INTERACTION: CURRENT RECOMMENDATIONS
 
Ukjpb article dr. luisetto
Ukjpb article dr. luisettoUkjpb article dr. luisetto
Ukjpb article dr. luisetto
 
Therapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptxTherapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptx
 
Anae12972
Anae12972Anae12972
Anae12972
 
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
1Respond to 2 people. Heidi and Pearl, by suggesting additiona.docx
 
Therapeutics-1-Copy.pdf
Therapeutics-1-Copy.pdfTherapeutics-1-Copy.pdf
Therapeutics-1-Copy.pdf
 
Thesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyThesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderly
 
The-Case-for-Practice-Integration[1]
The-Case-for-Practice-Integration[1]The-Case-for-Practice-Integration[1]
The-Case-for-Practice-Integration[1]
 

Payer information Humanitarian Use Device therapy for gastroparesis

  • 1. K AEMMERER GRO U P, LLC PORTFOLIO EXAMPLE Kaemmerer Group, LLC • www.kaemmerergroup.com • info@kaemmerergroup.com • 612.293.5448 • www.linkedin.com/in/carolkaemmerer Client: Medtronic, Inc. Project: Monograph for healthcare payers on electrical neurostimulation for gastroparesis Objective: This 16-page monograph sets the stage for healthcare payers to be willing to pay for a new therapy for a rare disease. Description of This monograph explains the rare monograph: condition of gastroparesis, the various treatment options for this condition, and introduces a Medtronic therapy that has a Humanitarian Device Exemption for gastroparesis, Enterra® Therapy. Clinical literature is summarized and referenced. Visual elements Because the audience for this monograph is healthcare payers and Medtronic’s message was to educate rather to make a sale, we deliberately chose a simple, two-color format. The treatment algorithm (see blue box at right) is something that communicates efficiently to our audience of healthcare payers. It indicates the steps that a doctor would take in the process of diagnosing gastroparesis and in what order treatment options would be used to address symptoms. Note that Enterra Therapy is near the bottom of the treatment algorithm. This indicates that it is appropriate to treat the condition with other more conservative therapies before considering Enterra Therapy which involves an implantable medical device. Copy close-up “Prokinetic drugs can be used to promote gastric emptying. Metoclopramide (Reglan® ), which has both prokinetic and antiemetic properties, is the only drug approved for the treatment of diabetic gastroparesis. Metoclopramide has central dopanergic actions that may result in such severe central nervous system side effects that 10% of patients are required to withdraw from medication. Controlled studies have shown that cisapride (Propulsid® ) can improve gastric emptying, but not other symptoms of gastroparesis.3-7 … Prokinetic drugs are associated with side effects such as cardiac arrhythmias, abdominal cramping, diarrhea, and nervousness.” [End of excerpt.] Note the didactic, factual style of the writing, which is appropriate to the audience for the piece and its purpose. Clinical literature is referenced throughout the monograph.